DeepMed Research

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Phase 2

Completed

Conditions: Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions: Drug: cyclophosphamide
Drug: fludarabine phosphate
Drug: mycophenolate mofetil
Drug: tacrolimus
Procedure: allogeneic bone marrow transplantation
Radiation: radiation therapy

First Posted Date: 2005-08-24

Last Posted Date: 2015-10-06

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 210

Registration Number: NCT00134004

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia, United States
🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

Phase 2

Completed

Conditions: Lymphoma
Leukemia

Interventions: Biological: Filgrastim
Biological: Rituximab
Drug: Cyclophosphamide
Drug: Cytarabine
Drug: Methotrexate
Drug: Prednisone
Drug: Hydrocortisone
Drug: Vincristine
Drug: Leucovorin

First Posted Date: 2005-08-24

Last Posted Date: 2018-09-17

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 23

Registration Number: NCT00133991

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Drexel University College of Medicine - Center City Hahnemann Campus, Philadelphia, Pennsylvania, United States

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

Phase 2

Completed

Conditions: Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions: Drug: Busulfan
Drug: Cyclophosphamide

First Posted Date: 2005-08-24

Last Posted Date: 2018-08-31

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 142

Registration Number: NCT00134017

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma

Phase 1

Completed

Conditions: Lymphoma

Interventions: Biological: KGEL vaccine
Biological: Filgrastim
Biological: Rituximab
Drug: Cyclophosphamide

First Posted Date: 2005-08-24

Last Posted Date: 2019-02-26

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 31

Registration Number: NCT00134082

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

Phase 1

Completed

Conditions: Cervical Cancer
Precancerous Condition

Interventions: Biological: pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine

First Posted Date: 2005-07-21

Last Posted Date: 2018-07-20

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 16

Registration Number: NCT00121173

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer

Phase 2

Terminated

Conditions: Head and Neck Cancer

Interventions: Drug: irinotecan hydrochloride

First Posted Date: 2005-01-07

Last Posted Date: 2018-12-06

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 6

Registration Number: NCT00100828

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2004-11-09

Last Posted Date: 2011-04-22

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 36

Registration Number: NCT00095771

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Completed

Conditions: Bladder Cancer

First Posted Date: 2004-11-08

Last Posted Date: 2019-02-08

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 125

Registration Number: NCT00095589

Locations: 🇺🇸
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Stanford Cancer Center, Stanford, California, United States

and more 10 locations

A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss

Phase 2

Completed

Conditions: Cancer
Chronic Obstructive Pulmonary Disease
Chronic Heart Failure
Rheumatoid Arthritis
Cancer Cachexia

First Posted Date: 2004-10-21

Last Posted Date: 2019-01-18

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 25

Registration Number: NCT00094562

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2004-10-08

Last Posted Date: 2023-07-03

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 60

Registration Number: NCT00093834

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy